ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo in 1L mNSCLC: AE Management in POSEIDON Trial
By
ASCO 2022 Conference Coverage
FEATURING
Byoung Chul Cho
By
ASCO 2022 Conference Coverage
FEATURING
Byoung Chul Cho
60 views
June 23, 2022
Comments 0
Login to view comments.
Click here to Login
Lung